Home › CIRM

CIRM

News Story
7/9/2014
Posted by Mark Reback
Two days after the ex-president of California’s stem cell agency became a board director at a company that is receiving funding from the agency, the agency said Wednesday it is taking steps to “mitigate a potential conflict of interest.” Earlier this week, StemCells Inc. in Newark said that Dr. Alan Trounson would join its board...
News Story
7/9/2014
Posted by Mark Reback
Alan Trounson, until very recently president of the California Institute for Regenerative Medicine (CIRM), has accepted a position on the board of StemCells, Inc., a company that has had $19,399,504 in grants from CIRM. If the clinical trials that CIRM is partly funding pay off, he could make a bundle on stock options (details of his compensation...
News Story
7/8/2014
Posted by Mark Reback
StemCells Inc.’s board of directors now includes the former president of the California stem cell agency that gave the company $19.4 million in research funding. StemCells Inc., a Newark company developing stem cell-based therapies, said Monday Dr. Alan Trounson is joining its board of directors, noting that he previously oversaw “the...
News Story
7/8/2014
Posted by Mark Reback
The San Francisco Chronicle today carried a story on the appointment of Alan Trounson, former president of the $3 billion California stem cell agency, to the board of  StemCells, Inc., which has received $19.4 million from the research program. Trounson’s appointment came only seven days after he left state employment. Last year,...
News Story
7/7/2014
Posted by Mark Reback
In laboratories across California, scientists are racing to turn stem cells into therapies for some of the world's most debilitating illnesses from cancer to Alzheimer's. Many of those researchers have received funding from a unique source: California's stem cell agency. Created by voters a decade ago, the California Institute for...
News Story
2/13/2013
Posted by Mark Reback
Proposed Changes To Oversight Panel For California's Stem Cell Agency Garner Backing   Supporters of California's $3 billion stem cell research program are endorsing proposed changes to remove conflicts of interest and build public trust. While the agency has won praise for supporting research on cures for disease and injuries,...
News Story
1/30/2013
Posted by Mark Reback
The California agency's board is wrestling with recommendations for changes in its membership and its authority over the spending of its $3-billion endowment. Compromise, defined as the art of getting part of a loaf when the whole loaf is out of reach, comes in many forms. But surely the strangest of all is what comes of trying to compromise...
News Story
1/29/2013
Posted by Mark Reback
California's stem cell agency, which oversees $3 billion in research funds, has announced plans to address long-standing conflict of interest concerns involving its governing board. Under the new policy, tentatively approved last week, the 13 board members of the California Institute for Regenerative Medicine who represent institutions...
News Story
1/24/2013
Posted by Mark Reback
California’s US$3-billion stem-cell agency plans to make a few changes in response to an assessment last month by the Institute of Medicine, an outside panel of scientific experts. The governing board of the California Institute for Regenerative Medicine (CIRM) voted overwhelmingly to endorse a set of recommendations made by the chair of...
Blog Post
1/23/2013
Posted by John M. Simpson
It looks like the message is finally getting through to California's stem cell agency board.  The board has a fundamental conflict of interest -- 13 permanent slots are for representatives of the very institutions that receive 90 percent of the funding. Consumer Watchdog has been pointing out this flaw since the passage of Proposition 71...